PDF(Sci-hub)
Abstract：
OBJECTIVE: To evaluate implementation of safety standards of compounded sterile preparations in different hospitals.
METHODS: This cross-sectional study included 124 hospitals from 19 countries. A survey was developed based on the guidelines and safety practices of the Institute for Safe Medication Practices (ISMP) for sterile preparations compounding, and was sent to the members of the Intravenous and Parenteral Nutrition experts\' network (IV PN experts\' network) in the Gulf region and beyond using SurveyMonkey software.
RESULTS: 124 pharmacists were invited to participate in this study. Only 39 (31.5%) pharmacists from seven countries responded: 16 (41%) of the participants were pharmacy supervisors, and 23 (59%) had >10 years of work experience. However, a majority, 27 (69%), of the respondents were from Saudi Arabia. Written policies and procedures for sterile preparations compounding were available in 37 (95%) hospitals. The concentrated electrolytes were removed from all patient care areas in 28 (72%) hospitals, and 30 (77%) hospitals clearly labelled those as high-alert medications. The use of advanced technologies, such as bar code verification or IV robotics, for compounding sterile preparations were not implemented in 27 (69%) hospitals.
CONCLUSIONS: Minimum standards and best practice recommendations to ensure safety of sterile preparation compounding were implemented in many hospitals of different countries. However, advanced technologies were not implemented by the majority of the hospitals.
METHODS: This cross-sectional study included 124 hospitals from 19 countries. A survey was developed based on the guidelines and safety practices of the Institute for Safe Medication Practices (ISMP) for sterile preparations compounding, and was sent to the members of the Intravenous and Parenteral Nutrition experts\' network (IV PN experts\' network) in the Gulf region and beyond using SurveyMonkey software.
RESULTS: 124 pharmacists were invited to participate in this study. Only 39 (31.5%) pharmacists from seven countries responded: 16 (41%) of the participants were pharmacy supervisors, and 23 (59%) had >10 years of work experience. However, a majority, 27 (69%), of the respondents were from Saudi Arabia. Written policies and procedures for sterile preparations compounding were available in 37 (95%) hospitals. The concentrated electrolytes were removed from all patient care areas in 28 (72%) hospitals, and 30 (77%) hospitals clearly labelled those as high-alert medications. The use of advanced technologies, such as bar code verification or IV robotics, for compounding sterile preparations were not implemented in 27 (69%) hospitals.
CONCLUSIONS: Minimum standards and best practice recommendations to ensure safety of sterile preparation compounding were implemented in many hospitals of different countries. However, advanced technologies were not implemented by the majority of the hospitals.
摘要：
目的：评价不同医院复方无菌制剂安全性标准的执行情况。
方法：这项横断面研究包括来自19个国家的124家医院。根据安全用药实践研究所（ISMP）的无菌制剂配制指南和安全实践进行了调查，并使用SurveyMonkey软件发送给海湾地区及其他地区的静脉和肠胃外营养专家网络（IVPN专家网络）的成员。
结果：邀请124名药剂师参与本研究。来自7个国家的39名（31.5%）药剂师回答：16名（41%）参与者是药房主管，23人(59%)的工作经验>10年。然而,多数,27（69%），受访者来自沙特阿拉伯。37家（95％）医院提供了无菌制剂配制的书面政策和程序。从28家（72％）医院的所有患者护理区域去除浓缩电解质，30家(77%)医院将这些药物明确标记为高度戒备药物。使用先进的技术，如条形码验证或IV机器人，对于复合无菌制剂,27家(69%)医院未实施.
结论：在不同国家的许多医院实施了确保无菌制剂复合安全的最低标准和最佳实践建议。然而,大多数医院没有实施先进技术。
方法：这项横断面研究包括来自19个国家的124家医院。根据安全用药实践研究所（ISMP）的无菌制剂配制指南和安全实践进行了调查，并使用SurveyMonkey软件发送给海湾地区及其他地区的静脉和肠胃外营养专家网络（IVPN专家网络）的成员。
结果：邀请124名药剂师参与本研究。来自7个国家的39名（31.5%）药剂师回答：16名（41%）参与者是药房主管，23人(59%)的工作经验>10年。然而,多数,27（69%），受访者来自沙特阿拉伯。37家（95％）医院提供了无菌制剂配制的书面政策和程序。从28家（72％）医院的所有患者护理区域去除浓缩电解质，30家(77%)医院将这些药物明确标记为高度戒备药物。使用先进的技术，如条形码验证或IV机器人，对于复合无菌制剂,27家(69%)医院未实施.
结论：在不同国家的许多医院实施了确保无菌制剂复合安全的最低标准和最佳实践建议。然而,大多数医院没有实施先进技术。
